0001193125-20-164628.txt : 20200710 0001193125-20-164628.hdr.sgml : 20200710 20200609160304 ACCESSION NUMBER: 0001193125-20-164628 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avidity Biosciences, Inc. CENTRAL INDEX KEY: 0001599901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461336960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-401-7900 MAIL ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Avidity Biosciences LLC DATE OF NAME CHANGE: 20161227 FORMER COMPANY: FORMER CONFORMED NAME: Avidity NanoMedicines LLC DATE OF NAME CHANGE: 20140211 CORRESP 1 filename1.htm CORRESP

June 9, 2020

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention:     Ada D. Sarmento

 

Re:

Avidity Biosciences, Inc.

 

Registration Statement on Form S-1 (File No. 333-238612)

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), we wish to advise that between June 8, 2020 and the date hereof, approximately 3,700 copies of the Preliminary Prospectus, dated June 8, 2020, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

We wish to advise you that the participating underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:00 p.m. Eastern Time, on Thursday, June 11, 2020 or as soon thereafter as practicable.

[signature page follows]

Very truly yours,
COWEN AND COMPANY, LLC
SVB LEERINK LLC
CREDIT SUISSE SECURITIES (USA) LLC
WELLS FARGO SECURITIES, LLC
As representatives of the Underwriters
COWEN AND COMPANY, LLC
By:  

/s/ Tanya Joseph

Name:   Tanya Joseph
Title:   Managing Director
SVB LEERINK LLC
By:  

/s/ Daniel Dubin

Name:   Daniel Dubin
Title:   Vice Chairman
CREDIT SUISSE SECURITIES (USA) LLC
By:  

/s/ John Hoffman

Name:   John Hoffman
Title:   Managing Director, ECM
WELLS FARGO SECURITIES, LLC
By:  

/s/ Geoffrey Goodman

Name:   Geoffrey Goodman
Title:   Managing Director

[Signature Page to Acceleration Request Letter]